Ascendis Pharma A (ASND) Inventory Average (2021 - 2026)
Ascendis Pharma A (ASND) posted Inventory Average of $359.5 million for Q1 2026, up 2.12% sequentially from $352.0 million in Q4 2025, and up 15.2% YoY from $312.1 million in Q1 2025.
Ascendis Pharma A (ASND) Inventory Average (2021 - 2026) Analysis & Trends
Ascendis Pharma A has reported Inventory Average for 6 years, with the latest figure at $359.5 million in Q1 2026.
- Quarterly Inventory Average rose 15.2% year-over-year to $359.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $359.5 million (up 15.2% YoY) and the FY2025 annual result came in at $333.4 million, up 23.07% from the prior year.
- Inventory Average improved to $359.5 million in Q1 2026 per ASND's latest filing, from $352.0 million in the prior quarter.
- Over five years, Inventory Average peaked at $359.5 million in Q1 2026 and troughed at $95.0 million in Q1 2022.
- A 5-year average of $231.7 million and a median of $238.8 million in 2024 frame the typical range for Inventory Average.
- The sharpest annual moves came in 2023 and 2026: Inventory Average soared 82.55% in 2023, then increased 15.2% in 2026.
- Over 5 years, Inventory Average stood at $119.1 million in 2022, then jumped by 80.84% to $215.3 million in 2023, then soared by 41.03% to $303.7 million in 2024, then rose by 15.92% to $352.0 million in 2025, then gained by 2.12% to $359.5 million in 2026.
- According to Business Quant data, Inventory Average over the past three periods registered $359.5 million, $352.0 million, and $348.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.09 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 707.10 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 355,998.06 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 90.57 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 137.65 Mn |
| 10 | Ascendis Pharma A | 15.40 Bn | 14.73 Bn | 268.20 Mn | 359.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 359.51 Mn |
| Dec 31, 2025 | 352.04 Mn |
| Sep 30, 2025 | 348.25 Mn |
| Jun 30, 2025 | 325.85 Mn |
| Mar 31, 2025 | 312.08 Mn |
| Dec 31, 2024 | 303.70 Mn |
| Sep 30, 2024 | 281.01 Mn |
| Jun 30, 2024 | 261.64 Mn |
| Mar 31, 2024 | 238.79 Mn |
| Dec 31, 2023 | 215.34 Mn |
| Sep 30, 2023 | 194.37 Mn |
| Jun 30, 2023 | 172.38 Mn |
| Mar 31, 2023 | 147.62 Mn |
| Dec 31, 2022 | 119.08 Mn |
| Sep 30, 2022 | 106.48 Mn |
| Jun 30, 2022 | 105.93 Mn |
| Mar 31, 2022 | 95.00 Mn |
| Dec 31, 2021 | 75.72 Mn |